Pharma Journalist 7888 posts 0 comments

Abbisko Therapeutics Co., Ltd. announced that its CSF-1R inhibitor pimicotinib (ABSK021) has been granted the fast track designation ("FTD") by the U.S. FDA for the treatment of…
Read More...

Almirall, S.A. (ALM), a global pharmaceutical company focused on medical dermatology, and etherna, an mRNA/LNP technology platform company, announced a multi-target alliance to discover…
Read More...

AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential…
Read More...

Pfizer Inc. announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired December 11, 2023, with respect to Pfizer’s pending…
Read More...

Codexis, Inc. announced it has entered into an agreement with Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech…
Read More...

Interactomics pioneer Depixus has entered a collaboration with Daiichi Sankyo to use their novel MAGNA technology to accelerate the Japanese healthcare leader’s RNA-targeted drug…
Read More...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a regulatory application to extend the indication of GSK’s respiratory syncytial…
Read More...

Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announced a $38 million Series A financing – one of the largest raises to advance women’s…
Read More...

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, today announced the successful completion of the squeeze-out merger under Swiss law (the “Squeeze-Out Merger”) pursuant…
Read More...

Synplogen Co., a synthetic biology startup spun out of Kobe University's Graduate School of Science, Technology and Innovation that provides custom DNA synthesis and Gene Therapy…
Read More...